Devex: Aid groups grapple with stigmatization in HIV prophylaxis rollout
“…[Pre-exposure prophylaxis’ (PrEP)] success in sub-Saharan Africa — the region with the highest burden of HIV — will hinge more on the social than the scientific, though. Researchers and advocates will have to strike a balance in how they market and roll out PrEP. They have to ensure that it reaches stigmatized populations with high HIV transmission rates, such as [men who have sex with men (MSM)] and sex workers. Meanwhile, they must ensure it is not perceived as exclusively a treatment for marginalized groups, which will lower its appeal both within those communities but also to other people who could benefit from it…” (Green, 11/18).